Mednet Logo
SpecialtiesHospital Medicine
Hospital Medicine

Hospital Medicine

Physician discussions on inpatient care, transitions of care, diagnostic reasoning, and hospital-based protocols.

Recent Discussions

Should we recommend SGLT2i initiation at discharge to all patients hospitalized with acute myocardial infarction?

2
1 Answers

Mednet Member
Mednet Member
Endocrinology · Duke Endocrinology Clinic

The strict answer to this question, including "all patients hospitalized with acute MI" is no based on the results of the recently reported EMPACT-MI trial. In this study of more than 6000 patients empagliflozin did not significantly improve a composite endpoint of hospitalization for heart failure ...

Do you ever employ the use of prolonged periods of pressure support ventilation as means of "weaning" in the management of patients with acute respiratory failure?

1 Answers

Mednet Member
Mednet Member
Pulmonology · The Permanente Medical Group-NCAL

The evidence basis here would suggest no one mode is superior for weaning vs just putting patients on SBT. However, as a practical matter, weaning a patient from the ventilator involves letting sedatives metabolize/wear off (propofol can take days to wash out after a week of use), and testing how th...

How do you approach the management of capmatinib induced edema?

1
1 Answers

Mednet Member
Mednet Member
Medical Oncology · University of California Los Angeles

I don't know that I can give a comprehensive approach to the edema associated with capmatinib, but I can give a couple of observations that I think may help practitioners. Dose reduction can help if other measures don't accomplish what is wanted. I have several patients in their late 80s and early 9...

In patients being evaluated for brain death, which abnormal movements are definitively known to still be consistent with brain death and which are possibly consistent with brain death but lack definitive evidence?

1
1 Answers

Mednet Member
Mednet Member
Neurology · UC Davis Health

This is indeed a challenging question, one that I continue to grapple with as a neurointensivist. Fortunately, most brain-dead patients do not exhibit any movements in response to noxious stimuli, but some case series report reflexive movement in up to 75% of cases. The classic teaching is that only...

Do you recommend immediate catheter removal or anticoagulating for a certain amount of time before removing the tunneled dialysis catheter of a patient with an incidentally found, asymptomatic thrombus at the end of the catheter that does not interfere with hemodialysis?

2
2 Answers

Mednet Member
Mednet Member
Nephrology · LSU Health Sciences Center - Shreveport

I agree with Dr. @Dr. First Last. Since this tunneled dialysis catheter (TDC) is functioning well, there is no urgency to remove it. Infact, removal runs the risk of dislodging the thrombus causing pulmonary embolism. I would provide systemic anticoagulation with a vitamin K antagonist (coumadin) us...

Do you routinely check cefepime levels in patient's with suspected cefepime-induced neurotoxicity?

1 Answers

Mednet Member
Mednet Member
Infectious Disease · Pacific Inpatient Medical Group

No. I would never get the result soon enough. I just change the antibiotic.

For patients who have undergone ablation for atrial fibrillation with elevated bleeding risk, what is your risk/benefit approach when deciding to continue oral anticoagulation long-term?

3
1 Answers

Mednet Member
Mednet Member
Cardiology · Yale University School of Medicine

I would generally determine the continuation of anticoagulation based on the patient's ChADSVASC score rather than the perceived success of ablation as many will have a burden of subclinical PAF despite ablation. So, if they are at high risk for stroke/systemic embolism, based on ChADSVASC, I would ...

How do you medically manage acute basilar artery occlusion in patients with low NIHSS who are not candidates for EVT but at risk for deterioration?

1
2 Answers

Mednet Member
Mednet Member
Neurology · Vanderbilt University Medical Center

First, I would consider endovascular therapy even with a low NIHSS, if the patient is otherwise a good candidate. If this were not possible, I would angicoagulate with IV heparin initially, then a DOAC (direct oral anticoagulant).

At what ferritin threshold would a patient with anemia of inflammation or malignancy no longer benefit from iron supplementation for functional iron deficiency?

3
1 Answers

Mednet Member
Mednet Member
Hematology · Georgetown University School of Medicine

There is no level. I have given IV iron to people with low TSATs and ferritins in the thousands. 200 isn't even close to too high.

Do you avoid ESA use in patients with anemia and chronic kidney disease who also have APLS and risk for thrombosis?

1
2 Answers

Mednet Member
Mednet Member
Nephrology · University Of California San Francisco Medical Center At Parnassus

I normally don't. I would make sure the patient is getting anticoagulated if indicated. I don't believe making the hemoglobin closer to normal in the setting of being anticoagulated increases thrombosis risk that much. I would shoot for a hemoglobin goal of 10-11.